SEC Filing Summary: National Medical Enterprises, Inc. (10-K)
Business Context and Reporting Period
Company: National Medical Enterprises, Inc. (NME)
Filing Type: Form 10-K (Annual Report)
Period Ended: May 31, 1994
Business Overview: NME is an investor-owned health care company operating general hospitals domestically and internationally. Fiscal 1994 was a transformative year marked by a complete change in top management and a strategic pivot to focus on core general hospital operations. The Company initiated the divestiture of its Psychiatric Division and sold the majority of its rehabilitation hospitals.
Key Financial Metrics
Revenue and Profitability:
- Income from Continuing Operations (1994): $215.9 million.
- Earnings Per Share (Primary): $1.29.
- Earnings Per Share (Fully Diluted): $1.23.
- Revenue Mix: 94.6% derived from the Hospital Division; 5.4% from Other Businesses.
- Domestic General Hospitals: 35 facilities with 6,873 licensed beds.
- Occupancy Rate: 47% (down from 48% in 1993).
- Employees: Approximately 38,800 total (28,500 in Hospital Division).
- Real Estate Debt: Approximately $171 million in loans secured by real property and $49 million in capitalized lease obligations.
- Short-Term Borrowings (End of Period): $66 million (banks) and $1 million (other institutions).
- Weighted Average Interest Rate: 4.1% (banks) and 3.1% (other).
- Dividend Received: $75.5 million dividend received from Medical Ambulatory Care (MAC) in Q1 1995 (post-period).
Note: Specific cash flow from operations, total debt, and liquidity ratios are not explicitly detailed in the provided text, as the full financial statements are incorporated by reference.
Material Changes vs. Prior Period
- Discontinued Operations: The Psychiatric Division was designated as discontinued operations effective November 30, 1993. NME sold 15 facilities during the year and entered agreements to sell 47 more to Charter Medical Corporation (27 closed by June 30, 1994).
- Rehabilitation Division: Sold 29 of 35 rehabilitation hospitals (28 to HEALTHSOUTH for ~$350 million; 1 to a third party for ~$14 million), retaining only six "Campus Rehabilitation Hospitals."
- Legal Settlements: Settled federal investigations and state claims regarding psychiatric facilities. Agreed to pay $362.7 million to the federal government and approximately $16.3 million to 27 states and the District of Columbia. Settled insurance litigation for $214.9 million ($125 million + $89.9 million).
- Hillhaven Restructuring: Sold 23 long-term care facilities to Hillhaven for $111.8 million; Hillhaven repaid $149 million in loans; NME was released from ~$370 million of contingent liabilities.
- International Expansion: Acquired 100% ownership of Centro Medico Teknon in Spain; entered a joint venture for a new hospital in Bangkok, Thailand.
Guidance, Outlook, and Risks
Management Commentary:
Management prioritized resolving legal proceedings and focusing on core general hospital operations. A management consulting study identified $32 million in projected annual overhead savings, leading to the elimination of 240 corporate and regional positions.
Risks and Contingencies:
- Health Care Reform: Significant uncertainty regarding federal and state health care reform proposals, which could impact reimbursement rates and patient access.
- Reimbursement Pressures: Continued reduction in payments from Medicare, Medicaid, and private payors due to utilization review and managed care contracts. DRG rates for urban hospitals are expected to be adjusted downward by 2.5% effective October 1, 1994.
- Legal: Pending shareholder derivative and class-action lawsuits regarding alleged fraud and conspiracy in the psychiatric division (mediation ongoing). Pending FTC approval for the sale of 17 psychiatric facilities to Charter Medical.
- Compliance: Required to implement a corporate compliance program and divest remaining psychiatric facilities (except campus facilities) by November 30, 1995.
Investor Verification Checklist
- Legal Settlement Finality: Verify the final court approval of the $362.7 million federal settlement and the $16.3 million state settlements.
- Psychiatric Divestiture: Confirm the status of the FTC review for the remaining 17 facilities to be sold to Charter Medical and the timeline for closing.
- Shareholder Litigation: Monitor the outcome of the voluntary mediation for the consolidated securities class-action lawsuits.
- Reimbursement Impact: Assess the financial impact of the 2.5% reduction in Medicare DRG rates effective October 1994 on future margins.
- Cost Reduction: Verify the realization of the projected $32 million in annual overhead savings from the workforce reduction.